P Roux-Lombard
Overview
Explore the profile of P Roux-Lombard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
1543
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meyer B, Torriani G, Yerly S, Mazza L, Calame A, Arm-Vernez I, et al.
Clin Microbiol Infect
. 2020 Jul;
26(10):1386-1394.
PMID: 32603801
Objectives: To validate the diagnostic accuracy of a Euroimmun SARS-CoV-2 IgG and IgA immunoassay for COVID-19. Methods: In this unmatched (1:2) case-control validation study, we used sera of 181 laboratory-confirmed...
2.
Finckh A, Alpizar-Rodriguez D, Roux-Lombard P
Clin Pharmacol Ther
. 2017 Jul;
102(4):585-587.
PMID: 28722123
Recent diagnostic advances allow to identify persons in a pre-symptomatic stage of rheumatoid arthritis (RA), opening the way for a preventive therapeutic intervention, which may potentially be curative. We review...
3.
Pisetsky D, Trace S, Brownley K, Hamer R, Zucker N, Roux-Lombard P, et al.
Cytokine
. 2014 Jul;
69(1):110-5.
PMID: 25022969
Anorexia nervosa (AN) is a serious, potentially life-threatening disorder characterized by severe weight loss, dysregulated eating, and often excessive exercise. While psychiatric illnesses such as depression are associated with increased...
4.
Wick P, Mombelli A, Pagano S, Moren X, Giannopoulou C, Mach F, et al.
J Periodontal Res
. 2012 Oct;
48(3):350-6.
PMID: 23050768
Background And Objective: Anti-apolipoprotein A-1 (anti-apoA-1) IgG is a potential marker of atherosclerotic plaque vulnerability and cardiovascular complications. In patients with periodontitis the presence of anti-apoA-1 IgGs in serum and...
5.
Girardin F, Daali Y, Gex-Fabry M, Rebsamen M, Roux-Lombard P, Cerny A, et al.
J Viral Hepat
. 2012 Jul;
19(8):568-73.
PMID: 22762141
Liver kidney microsomal type 1 (LKM-1) antibodies have been shown to decrease the CYP2D6 activity in vitro and are present in a minority of patients with chronic hepatitis C infection....
6.
Pagano S, Satta N, Werling D, Offord V, de Moerloose P, Charbonney E, et al.
J Intern Med
. 2012 Feb;
272(4):344-57.
PMID: 22329401
Objectives: Toll-like receptor (TLR)-mediated vascular inflammation, inducible by - amongst other factors - auto-antibodies, is increasingly recognized as a potential mediator of cardiovascular disease. We investigated whether anti-apolipoprotein (Apo)A-1 IgG...
7.
Keller P, Pagano S, Roux-Lombard P, Sigaud P, Rutschmann O, Mach F, et al.
J Intern Med
. 2011 Nov;
271(5):451-62.
PMID: 22061093
Objectives: To explore the diagnostic accuracies of anti-apolipoproteinA-1 (anti-ApoA-1) IgG and anti-phosphorylcholine (anti-PC) IgM alone, expressed as a ratio (anti-ApoA-1 IgG/anti-PC IgM), and combined with the Thrombolysis In Myocardial Infarction...
8.
Ninet B, Roux-Lombard P, Schrenzel J, Janssens J
Rev Mal Respir
. 2011 Jul;
28(6):823-33.
PMID: 21742243
Over the last decade, molecular biology techniques for identifying mycobacteria in pulmonary secretions have become more and more sensitive and rapid, even in smear negative samples. Nuclear amplification techniques also...
9.
Roux-Lombard P, Pagano S, Montecucco F, Satta N, Vuilleumier N
Clin Rev Allergy Immunol
. 2010 Dec;
44(1):84-97.
PMID: 21188647
During the last 15 years, a growing body of evidence supported the fact that auto-antibodies represent not only emergent markers but also active mediators of cardiovascular disease (CVD), clinically represented...
10.
Dayer E, Kesseler D, Morandi P, Albe X, Roux-Lombard P
Rev Med Suisse
. 2010 May;
6(245):817-22.
PMID: 20469664
External assessment of analytical performance is part of the quality assurance in medical laboratory. These external controls are mandatory in Switzerland since 2006 for IgE analysis. The Swiss Society for...